Akti-1/2
Tocris Bioscience | Catalog # 5773
Key Product Details
Description
Alternative Names
Product Description
Akti-1/2 is a potent and selective dual Akt1 and 2 inhibitor (IC50 values are 50 and 210 nM, respectively). Selective for Akt1 and 2 over a panel of other tyrosine and serine/threonine kinases. Sensitizes LnCaP cells to TRAIL (TNF-related apoptosis-inducing ligand) induced apoptosis. Also enhances CAR and TCR retroviral transduction of human T cells. Active in vivo.
Product Specifications for Akti-1/2
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 11.03 | 20 with gentle warming |
Preparing Stock Solutions for Akti-1/2
The following data is based on the product molecular weight 551.64.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.2 mM | 9.06 mL | 45.32 mL | 90.64 mL |
| 1 mM | 1.81 mL | 9.06 mL | 18.13 mL |
| 2 mM | 0.91 mL | 4.53 mL | 9.06 mL |
| 10 mM | 0.18 mL | 0.91 mL | 1.81 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 22 publications citing the usage of this product.
- Klebanoff Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy. JCI Insight 2017 PMID: 29212954
- Bain The selectivity of protein kinase inhibitors: a further update. Biochem.J. 2007 PMID: 17850214
- Barnett Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors. Biochem. J. 2005 PMID: 15456405
- Lindsley Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors. Bioorg.Med.Chem.Lett. 2005 PMID: 15664853
- DeFeo-Jones D Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members. Mol.Cancer Ther. 2005 PMID: 15713898
Product Documents for Akti-1/2
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for Akti-1/2
For research use only
Citations for Akti-1/2
Customer Reviews for Akti-1/2 (2)
Have you used Akti-1/2?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Customer Images
-
Species: HumanAssay Type: In VitroCell Line/Tissue: OsteosarcomaVerified Customer | Posted 12/13/2018Human osteosarcoma cells were incubated with 10 μM Akti-1/2 for 30 min prior to treatment with 10 μM LPA to estimate COX-2 expression using Western blot analysis. Akti-1/2 abolished LPA-induced COX-2 expression.
-
Species: HumanAssay Type: In VitroCell Line/Tissue: MG-63 osteosarcoma cellsVerified Customer | Posted 10/15/2018MG-63 cells were incubated with PD169316 (25 μM), LY294002 (10 μM) or Akt-1/2 (5 μM Akt-I) for 30 min prior to 15d-PGJ2 treatment (20 μM) for 1 h to follow pAkt expression using Western blot. Akt-1/2 completely blocked 15d-PGJ2-induced Akt phosphorylation in MG-63 cells.
There are no reviews that match your criteria.